• RL5_4266.jpg
    Olivér Várhelyi
    biocap 2026
    Lara Formichella
    Lara Formichella, Project Lead bio:cap and Olivér Várhelyi (European Commissioner for Health and Animal Welfare at European Commission)
    2026
    Allgemein
  • Assadollahi_0002.jpg
    biocap 2026
    biosphere stage
    Ramin Assadollahi
    Helena Smolak
    Prof. Dr. Ramin Assadollahi, Founder & Investor at HALBZEIT, Prof for AI at Clinical Research IT, University of Lübeck + Helena Smolak, Pharma Correspondent at Handelsblatt.
    2026
    Rahmenprogramm
  • Assadollahi_0007.jpg
    biocap 2026
    biosphere stage
    Ramin Assadollahi
    Helena Smolak
    Prof. Dr. Ramin Assadollahi, Founder & Investor at HALBZEIT, Prof for AI at Clinical Research IT, University of Lübeck + Helena Smolak, Pharma Correspondent at Handelsblatt.
    2026
    Rahmenprogramm
  • Birner_0003.jpg
    biocap 2026
    biosphere stage
    Hubert Birner
    Dr. Hubert Birner, Managing Partner at TVM Life Science Management GmbH.
    2026
    Rahmenprogramm
  • Birner_0004.jpg
    biocap 2026
    biosphere stage
    Hubert Birner
    Dr. Hubert Birner, Managing Partner at TVM Life Science Management GmbH.
    2026
    Rahmenprogramm
  • Blattner_0005.jpg
    biocap 2026
    biosphere stage
    Claudia Blattner
    Dr. Claudia Blattner, Vice President Business Development at Immatics.
    2026
    Rahmenprogramm
  • Bronsema_Petra_Rehse_0008.jpg
    biocap 2026
    biovision stage
    Helena Smolak
    Viola Bronsema
    Anca Petre
    Chris Rehse
    From left to right: Helena Smolak, Pharma Correspondent at Handelsblatt; Dr. Viola Bronsema, Managing Director at BIO Deutschland e.V.; Anca Petre, HealthTech Strategist, Co-Founder MedShake Studio & Creator of Tech Anatomy; Dr. Chris Rehse, Founder & CEO at HealthTech AI Venture.
    2026
    Rahmenprogramm
  • Costard_Renner_0005.jpg
    biocap 2026
    biovision stage
    Jano Costard
    Thomas Renner
    From left to right: Dr. Jano Costard, Head of Challenges at SPRIND + Thomas Renner, Director of the Directorate „Innovation and Digitalisation" at German Federal Ministry of Health.
    2026
    Rahmenprogramm
  • Costard_Renner_0007.jpg
    biocap 2026
    biovision stage
    Jano Costard
    Thomas Renner
    From left to right: Dr. Jano Costard, Head of Challenges at SPRIND + Thomas Renner, Director of the Directorate „Innovation and Digitalisation" at German Federal Ministry of Health.
    2026
    Rahmenprogramm
  • Costard_Renner_0008.jpg
    biocap 2026
    biovision stage
    Jano Costard
    Thomas Renner
    From left to right: Dr. Jano Costard, Head of Challenges at SPRIND + Thomas Renner, Director of the Directorate „Innovation and Digitalisation" at German Federal Ministry of Health.
    2026
    Rahmenprogramm
  • Costard_Renner_0010.jpg
    biocap 2026
    biovision stage
    Jano Costard
    Thomas Renner
    From left to right: Dr. Jano Costard, Head of Challenges at SPRIND + Thomas Renner, Director of the Directorate „Innovation and Digitalisation" at German Federal Ministry of Health.
    2026
    Rahmenprogramm
  • Costard_Renner_0011.jpg
    biocap 2026
    biovision stage
    Jano Costard
    Thomas Renner
    From left to right: Dr. Jano Costard, Head of Challenges at SPRIND + Thomas Renner, Director of the Directorate „Innovation and Digitalisation" at German Federal Ministry of Health.
    2026
    Rahmenprogramm
  • Diem_0004.jpg
    biocap 2026
    biosphere stage
    Michael Diem
    Michael Diem, Senior Managing Partner of Pfizer Ventures and Vice President at Pfizer.
    2026
    Rahmenprogramm
  • Diem_0008.jpg
    biocap 2026
    biosphere stage
    Michael Diem
    Michael Diem, Senior Managing Partner of Pfizer Ventures and Vice President at Pfizer.
    2026
    Rahmenprogramm
  • Diem_0009.jpg
    biocap 2026
    biosphere stage
    Michael Diem
    Michael Diem, Senior Managing Partner of Pfizer Ventures and Vice President at Pfizer.
    2026
    Rahmenprogramm
  • Duplat_0003.jpg
    biocap 2026
    biovision stage
    Bertrand Duplat
    Helena Smolak
    Bertrand Duplat, Co-Founder & CEO at Robeauté + Helena Smolak, Pharma Correspondent at Handelsblatt.
    2026
    Rahmenprogramm
  • Duplat_0006.jpg
    biocap 2026
    biovision stage
    Bertrand Duplat
    Helena Smolak
    Bertrand Duplat, Co-Founder & CEO at Robeauté + Helena Smolak, Pharma Correspondent at Handelsblatt.
    2026
    Rahmenprogramm
  • Duplat_0008.jpg
    biocap 2026
    biovision stage
    Bertrand Duplat
    Helena Smolak
    Bertrand Duplat, Co-Founder & CEO at Robeauté + Helena Smolak, Pharma Correspondent at Handelsblatt.
    2026
    Rahmenprogramm
  • Faisal_0001.jpg
    biocap 2026
    biosphere stage
    Aldo Faisal
    Prof. Dr. Aldo Faisal, Director UKRI Centre AI for Healthcare at Imperial College & Chair in Digital Health at University of Bayreuth.
    2026
    Rahmenprogramm
  • Giacomo_0001.jpg
    biocap 2026
    biosphere stage
    Angela de Giacomo
    Angela de Giacomo, Author & Chief Investment Officer at Single Family Office.
    2026
    Rahmenprogramm